<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01092936</url>
  </required_header>
  <id_info>
    <org_study_id>IRIS</org_study_id>
    <nct_id>NCT01092936</nct_id>
  </id_info>
  <brief_title>Italian Validation of the Revised MDS-Unified Parkinson's Disease Rating Scale</brief_title>
  <acronym>IRIS</acronym>
  <official_title>Italian Validation of the Revised MDS-Unified Parkinson's Disease Rating Scale</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione Neureca</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione Neureca</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study is part of an international program and deals with the translation and
      validation program for the Italian version of the MDS-UPDRS.

      The program will be articulated in three steps:

        -  Phase I: translation and back-translation of the MDS-UPDRS in Italian (completed)

        -  Phase II: Cognitive testing. This step is aimed at a preliminary testing of a subset of
           potentially culturally sensitive items in a limited set of PD patients (approximately
           10). Should this phase identify issues in the understanding and ease of use of some
           items a revised translation of some individual items might be envisaged.

        -  Phase III: large validation testing: this phase will involve 350 PD patients from 12-14
           Italian PD centres.

      The IRIS protocol deals with phase II and III of the program.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">December 2010</completion_date>
  <primary_completion_date type="Anticipated">December 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Phase II: To test the appropriateness of the Italian translation and clear understanding of potentially cultural-sensitive items. To refine the translation, if necessary, prior to validation testing.</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Phase III: the primary outcome of phase III is to confirm factorial analysis of the Italian version against the factor structure of the English version, by each of the four sections of the scale.</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The secondary outcome is to determine the Differential Item Function (DIF) which will be run on items by gender, race , disease severity, education and age.</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Parkinson's Disease</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Rating Scale administration</intervention_name>
    <description>Movement Disorder Society_Unified Parkinson's Disease Rating Scale will be submitted to the patient (with the help of the caregiver) in a single visit lasting about 40 minutes.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Native Italian-speaking PD patients ranging from mild to severe
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written and signed informed consent;

          -  native Italian-speaking patients or either sex;

          -  patients suffering from Parkinson's disease ranging from mild to severe, based on
             clinical judgement;

          -  presence of a native Italian-speaking caregiver.

        Exclusion Criteria:

          -  Patients with evidence of other central nervous system disorders;

          -  patients with a degree of depression or dementia which may prevent and/or affect
             ratings.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paolo Barone, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universita' Federico II di Napoli</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maurizio Zibetti, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Sanitaria Ospedaliera &quot;San Giovanni Battista di Torino&quot; Le Molinette</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Angelo Antonini, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale San Camillo IRCCS Venezia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gianni Pezzoli, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istituti Clinici di Perfezionamento Milano</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michele Tinazzi, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliera Universitaria Integrata Verona - Policlinico G.Rossi</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Giovanni Abbruzzese, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universita' di Genova</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ubaldo Bonuccelli, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universita' di Pisa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Giovanni Fabbrini, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universita' La Sapienza di Roma</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Letterio Morgante, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliera Universitaria Policlinico G.Martino di Messina</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mario Zappia, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliero-Universitaria Policlinico Vittorio Emanuele di Catania</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alberto Albanese, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istituto Neurologico &quot;Carlo Besta&quot; di Milano</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claudio Pacchetti</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istituto Neurologico Nazionale Fondazione IRCCS &quot;C. Mondino&quot; di Pavia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aldo Quattrone, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Policlinico Universitario Mater Domini di Catanzaro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Giovanni Cossu, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliera &quot;G. Brotzu&quot; di Cagliari</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aroldo Rossi, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universita' degli Studi di Perugia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paolo Martinelli, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universita' di Bologna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Silvia Campanella, Dr</last_name>
    <phone>+39 02 34535088</phone>
    <phone_ext>31</phone_ext>
    <email>campanella@mcr-med.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>M.Cristina Jori, Dr.</last_name>
    <phone>+39 02 34535088</phone>
    <phone_ext>23</phone_ext>
    <email>jori@mcr-med.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universita' Federico II di Napoli</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paolo Barone, Prof.</last_name>
      <phone>+39 081 7462670</phone>
      <email>barone@unina.it</email>
    </contact>
    <investigator>
      <last_name>Paolo Barone, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <link>
    <url>http://www.movementdisorders.org</url>
  </link>
  <reference>
    <citation>S. Fahn et al: The Unified Rating Scale for Parkinsonism. In Fahn, Marsden, Jenner, Teychenne eds.: Recent Developments in Parkinson's disease. N.J. Macmillan Healthcare Information: 153-63, 1987</citation>
  </reference>
  <reference>
    <citation>Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord. 2003 Jul;18(7):738-50. Review.</citation>
    <PMID>12815652</PMID>
  </reference>
  <reference>
    <citation>Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Van Hilten JJ, LaPelle N. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord. 2007 Jan;22(1):41-7.</citation>
    <PMID>17115387</PMID>
  </reference>
  <reference>
    <citation>Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N; Movement Disorder Society UPDRS Revision Task Force. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008 Nov 15;23(15):2129-70. doi: 10.1002/mds.22340.</citation>
    <PMID>19025984</PMID>
  </reference>
  <reference>
    <citation>Pagonabarraga J, Kulisevsky J, Llebaria G, García-Sánchez C, Pascual-Sedano B, Gironell A. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease. Mov Disord. 2008 May 15;23(7):998-1005. doi: 10.1002/mds.22007.</citation>
    <PMID>18381647</PMID>
  </reference>
  <verification_date>March 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 24, 2010</study_first_submitted>
  <study_first_submitted_qc>March 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 25, 2010</study_first_posted>
  <last_update_submitted>March 24, 2010</last_update_submitted>
  <last_update_submitted_qc>March 24, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 25, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr. Linda Toscano</name_title>
    <organization>Fondazione NEURECA</organization>
  </responsible_party>
  <keyword>Comparative fit index</keyword>
  <keyword>Movement Disorders' Society</keyword>
  <keyword>Unified Parkinson's Disease Rating Scale</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

